Peptide record

TPDB91801

Lactoferricin B Antibacterial Anticancer Antifungal Antiviral Toxicity modified_plain modified
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91801
Lactoferricin B
Antibacterial Anticancer Antifungal Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP pep-lab Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF Antifungipept CAFPdb AI4AVP
modified_plain
Yes
A 15-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
FKCRRWQWRMKKLGA-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
15 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antibacterial Antimicrobial Activity
Temporins family Activity
Evidence Records 5 records
Evidence 1 Activity

Activity

IC50
IC50=15.5 µM
Anticancer
15.5 µM

Target

Brain Tumor
Kelly
Brain

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2008

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50=29 µM
Anticancer
29 µM

Target

Brain Tumor
IMR-32
Brain

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2008
Evidence 3 Activity

Activity

IC50
IC50=37 µM
Anticancer
37 µM

Target

Brain Tumor
SK-N-DZ
Brain

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2008
Evidence 4 Activity

Activity

IC50
IC50=45 µM
Anticancer
45 µM

Target

Brain Tumor
SHEP-12
Brain

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2008
Evidence 5 Activity

Activity

IC50
IC50=60 µM
Anticancer
60 µM

Target

Brain Tumor
SH-SY-5Y2
Brain

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2008